This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Scripps Research Institute. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: **Innovative Approaches to Obesity Control: The Work of Eric P. Zorrilla**
Introduction
Eric P. Zorrilla, based in San Diego, CA, is an eminent inventor known for his significant contributions to the field of obesity treatment. With an innovative mindset, he has dedicated his efforts to developing novel methods to combat weight gain, addressing one of the pressing health challenges of our time.
Latest Patents
Zorrilla holds a patent titled "Vaccines and methods for controlling adiposity." This groundbreaking invention features immunoconjugates designed to impede weight gain and treat obesity in subjects. The immunoconjugates consist of specific ghrelin polypeptides combined with a suitable carrier moiety, offering a promising new approach to weight management.
Career Highlights
Zorrilla is affiliated with The Scripps Research Institute, an institution renowned for its pioneering research and innovative solutions in the life sciences. His work has not only advanced the scientific understanding of obesity but also opened new avenues for therapeutic interventions.
Collaborations
Throughout his career, Zorrilla has collaborated with notable colleagues, including Michael M. Meijler and Kim D. Janda. These collaborations have likely enriched his research and contributed to the success of his innovative projects.
Conclusion
In summary, Eric P. Zorrilla continues to make significant strides in the fight against obesity through his innovative patent and collaborative efforts at The Scripps Research Institute. His work exemplifies the impact of dedicated inventors in creating solutions for global health challenges.